The results of this study (summarized in Fig. 12) indicate that KSS and KKT may be viable options for the treatment of psychiatric disorders mediated by decreased KCC2 and our results may contribute to the development of causative therapies. This evidence concerns the gene SLC12A5 and psychiatric disorder.